Nellcor OxiFirst Verdict Contingent On NIH FOX Trial Results, Panel Agrees
This article was originally published in The Gray Sheet
Executive Summary
Upgraded software for Nellcor's OxiFirst N400 fetal pulse oximetry system will be included in NIH's Fetal Oximetry trial (FOX), as the company attempts to ward off adverse events associated with misuse of the device